Clinical Trials in Illinois

Showing 6281-6300 of 14,943 trials

S1916 Digital Medicine Program for Pain Control in Cancer Patients

NCT04194528

This is a feasibility study to assess the use of a Digital Medicine Program (consisting of an FDA-approved ingestible sensor co-encapsulated with oxycodone/acetaminophen (5 mg/325 mg), a small wearable patch, and a mobile application) in cancer patients with metastatic disease experiencing uncontrolled pain.

Metastatic Cancer

SWOG Cancer Research Network2 participantsStarted Jan 2020

Decatur, Illinois, United States • Urbana, Illinois, United States • Billings, Montana, United States +2 more locations

COMPLETEDPhase 335 miles

A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Treatment of Physician's Choice in Subjects With Advanced Non-Small Cell Lung Cancer

NCT01454934

This is a randomized, open-label, multicenter, Phase 3 study, comparing efficacy and safety of eribulin with TPC in subjects with advanced and disease progression following at least two prior regimens for advanced disease, which should have included a platinum-based regimen.

Non-Small Cell Lung Cancer (NSCLC)

Eisai Inc.540 participantsStarted Dec 2011

Los Angeles, California, United States • Pleasant Hill, California, United States • San Diego, California, United States +80 more locations

S1916 Digital Medicine Program for Pain Control in Cancer Patients

A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Treatment of Physician's Choice in Subjects With Advanced Non-Small Cell Lung Cancer

Find Trials by Condition in Illinois

Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia

Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer

The TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR)

Efficacy and Safety of Increasing Doses of DaxibotulinumtoxinA for Injection (DAXI for Injection) in the Treatment of Moderate or Severe Lateral Canthal Lines

The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of Age

Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLC

Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE

Eribulin Mesylate in Combination With Intermittent Erlotinib in Patients With Previously Treated, Advanced Non-Small Cell Lung Cancer

A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis

Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer

Medical Optimization of Management of Type 2 Diabetes Complicating Pregnancy (MOMPOD)

Clinical Performance of Senofilcon A Investigational Lens

Study of BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator(TM)), Prime + Boost, in Healthy Adults

Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease

Study of Adjunctive Ganaxolone Treatment in Female Children With Protocadherin 19 (PCDH19)-Related Epilepsy (Violet Study)

A Study of the Burden of Illness and Treatment Patterns in Teenagers and Adults With Hereditary Angioedema

The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 2)

COVID-19 and Anti-CD14 Treatment Trial